Gayatri BioOrganics Ltd

Gayatri BioOrga has faced significant financial challenges, reporting minimal revenue and consistent losses, with net sales dropping to zero in 2024 and 2025, and negative reserves of -114.68 Cr by March 2025. The company has not generated any cash flow from operations since March 2020.

Gayatri BioOrga has faced persistent financial challenges, with stagnant revenues, consistent losses, and negative shareholder funds, culminating in a significant loss of -1.01 crore in March 2023. The company's financial position has deteriorated, showing no operational activity over the last three years.

As of 24-Sep, Gayatri BioOrganics Ltd's stock price is declining at 11.83, down 3.11% today, with a total loss of 4.9% over the last two days. Despite strong long-term returns, recent performance shows decreased investor participation and a negative trend compared to benchmarks.

As of 23-Sep, Gayatri BioOrganics Ltd is priced at 12.26, down 1.45%. Despite a year-to-date return of 77.17%, recent declines indicate potential profit-taking and reduced investor interest, with a significant drop in delivery volume.

As of 22-Sep, Gayatri BioOrganics Ltd's stock price is at 12.44, having increased by 1.63% recently. Despite strong performance and significant year-to-date gains, declining investor participation may pose risks to its upward momentum.

As of 19-Sep, Gayatri BioOrganics Ltd is experiencing a price increase to 12.24, reflecting a 4.35% upward change. Despite strong short-term performance and significant annual returns, the stock's high volatility and weak long-term fundamentals raise concerns about its sustainability.

As of 18-Sep, Gayatri BioOrganics Ltd's stock price is declining at 11.73, down 2.57%, and underperforming its sector. Despite strong annual returns, the company faces significant challenges, including high debt and negative profitability, leading to decreased investor interest.

As of 17-Sep, Gayatri BioOrganics Ltd is experiencing a price increase to 12.04, reflecting a 2.29% rise. The stock shows strong upward momentum and significant investor participation, but faces risks due to negative book value and high debt levels.

As of 16-Sep, Gayatri BioOrganics Ltd's stock price is declining at 11.77, down 3.37%, with a total drop of 3.45% over the last two days. Despite strong year-to-date and one-year returns, weak fundamentals and declining investor interest are driving the recent downturn.

As of 15-Sep, Gayatri BioOrganics Ltd is priced at 12.18, down 0.08%, and has underperformed its sector today. Despite a strong monthly return of 6.84% and a year-to-date increase of 76.01%, recent declines in investor participation and a trend reversal may indicate reduced buying interest.

As of 12-Sep, Gayatri BioOrganics Ltd is priced at 12.19, reflecting a recent positive trend with a total return of 4.1% over three days. Despite strong short-term performance and impressive year-to-date returns, the company faces significant financial challenges that may deter investors.